Administrative Core
行政核心
基本信息
- 批准号:10359712
- 负责人:
- 金额:$ 16.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-03-06 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:AchievementAdvisory CommitteesAlphavirusAnimalsAwardBackCanis familiarisChargeChemistryCollaborationsCommunicationCommunitiesConsultConsultationsDataDevelopment PlansDocumentationDrug KineticsEnsureEvaluationFoundationsFundingFutureHealth SciencesHollyIACUCIn VitroInformation DisseminationInfrastructureIntellectual PropertyInvestigational New Drug ApplicationLaboratoriesLeadLeadershipMaximum Tolerated DoseModelingMonitorNational Institute of Allergy and Infectious DiseaseOutcomePilot ProjectsPublishingRattusResearchResearch Project GrantsResourcesSafetyScheduleSecureSiteSmall Business Innovation Research GrantTechnology TransferTennesseeTestingTherapeuticTimeToxicokineticsUnited States National Institutes of HealthUniversitiesValidationWisconsinWorkcommercializationefficacy studyin vivolead candidatemeetingsmembernonhuman primatenovelpre-clinicalproduct developmentprogramssafety study
项目摘要
Project Summary
The overall objective of the Administration (Admin) Core efforts is to provide a robust and dynamic
infrastructure for the Center of Excellence for Encephalitic Alphavirus Therapeutics that enables
consistent and notable progress through the milestones. Led by the Program Director, Dr. Jonsson
(UTHSC, University of Tennessee Health Science Center), the Core will be the main interface between
the Scientific Advisory Committee (SAC), the Research Project PIs, and NIAID. To support the
achievement of the aims and milestones of the Center, Dr. Jonsson will be supported by Jayne McKinnie
(Admin Core Associate) to: (1) ensure coordination and dissemination of information across the research
projects, (2) coordinate results required for filing intellectual property, (3) publish results of disclosed leads
and provide novel resources to the scientific community, (4) coordinate input into the refinement of the
product development plan outlined in the Overall section with our University partners and SAC, (4) attract
commercial partners for future SBIR or similar proposal efforts, and (5) administratively support the Center
in collaboration with our regulatory consultants to prepare for our meetings with the FDA at the end of year
3 and at the start of year 5. Specific aims of the Admin Core will be to: Aim 1. Organize, manage, and
document Center communications and findings; Aim 2. Manage and ensure fiscal responsibility and
regulatory compliance; and Aim 3. Manage lead prioritization and documentation, the refinement of the
Product Development Plan and a path to Commercialization.
项目摘要
核心工作的总体目标是提供一个强有力和充满活力的
脑炎甲病毒治疗卓越中心的基础设施,
通过里程碑取得一致且显着的进展。由项目主任Jonsson博士领导
(UTHSC,田纳西大学健康科学中心),核心将是
科学咨询委员会(SAC),研究项目PI和NIAID。支持
为了实现中心的目标和里程碑,Jayne McKinnie将支持Jonsson博士
(行政核心助理):(1)确保整个研究的协调和信息传播
项目,(2)协调知识产权备案所需的结果,(3)公布披露线索的结果
并为科学界提供新的资源,(4)协调对改进
与我们的大学合作伙伴和SAC一起制定总体部分中概述的产品开发计划,(4)吸引
为未来SBIR或类似提案工作提供商业合作伙伴,以及(5)在行政上支持中心
与我们的监管顾问合作,为年底与FDA的会议做准备
3、年初5。管理核心的具体目标将是:目标1。组织、管理和
文件中心的通信和调查结果;目标2.管理和确保财务责任,
合规;目标3。管理潜在客户优先级排序和文档,
产品开发计划和商业化途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Colleen B Jonsson其他文献
Colleen B Jonsson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Colleen B Jonsson', 18)}}的其他基金
Antiviral & Antimicrobial Countermeasures Discovery and Development Core
抗病毒物质
- 批准号:
10793955 - 财政年份:2023
- 资助金额:
$ 16.59万 - 项目类别:
Enhancement of Resilience of the UTHSC RBL Facility, Biosafety and Countermeasure Discovery
增强 UTHSC RBL 设施的弹性、生物安全和对策发现
- 批准号:
10793951 - 财政年份:2023
- 资助金额:
$ 16.59万 - 项目类别:
Center of Excellence for Encephalitic Alphavirus Therapeutics
脑炎甲病毒治疗卓越中心
- 批准号:
10631703 - 财政年份:2022
- 资助金额:
$ 16.59万 - 项目类别:
UTHSC Regional Biocontainment Laboratory: Upgrade of Facility and Building System
UTHSC 区域生物防护实验室:设施和建筑系统升级
- 批准号:
10393982 - 财政年份:2021
- 资助金额:
$ 16.59万 - 项目类别:
UTHSC RBL Administrative Supplement For Antiviral Discovery & Development
UTHSC RBL 抗病毒药物发现行政补充
- 批准号:
10636200 - 财政年份:2021
- 资助金额:
$ 16.59万 - 项目类别:
Center of Excellence for Encephalitic Alphavirus Therapeutics
脑炎甲病毒治疗卓越中心
- 批准号:
10116260 - 财政年份:2019
- 资助金额:
$ 16.59万 - 项目类别:
Center of Excellence for Encephalitic Alphavirus Therapeutics
脑炎甲病毒治疗卓越中心
- 批准号:
10563173 - 财政年份:2019
- 资助金额:
$ 16.59万 - 项目类别:
Center of Excellence for Encephalitic Alphavirus Therapeutics
脑炎甲病毒治疗卓越中心
- 批准号:
10359711 - 财政年份:2019
- 资助金额:
$ 16.59万 - 项目类别:
Evaluation of Optimized Lead Candidates for Encephalitic Alphaviruses in Animal Models
在动物模型中评估脑炎甲病毒的优化先导候选物
- 批准号:
10116266 - 财政年份:2019
- 资助金额:
$ 16.59万 - 项目类别:
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 16.59万 - 项目类别:
Standard Grant














{{item.name}}会员




